Non-pharmaceutical hypercholesterolemia management by plant stanol-enriched product consumption

Phytosterols and phytostanols are plant analogs of cholesterol, inhibiting cholesterol (XCH) absorption by intestine epithelium and, therefore, decreasing CH blood levels. Sterols and especially stanols are absorbed in the intestine to a much lesser extent than CH, and their plasma concentrations ar...

Full description

Bibliographic Details
Main Author: N. V. Perova
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2006-10-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1303
id doaj-cd8df63901d34c17a5d2fda67c72dd42
record_format Article
spelling doaj-cd8df63901d34c17a5d2fda67c72dd422021-07-28T13:50:43Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252006-10-015564691013Non-pharmaceutical hypercholesterolemia management by plant stanol-enriched product consumptionN. V. Perova0State Research Center for Preventive Medicine, State Federal Agency for Health and Social Development. MoscowPhytosterols and phytostanols are plant analogs of cholesterol, inhibiting cholesterol (XCH) absorption by intestine epithelium and, therefore, decreasing CH blood levels. Sterols and especially stanols are absorbed in the intestine to a much lesser extent than CH, and their plasma concentrations are also less than those of CH. It is known that rare cases of hypercholesterolemia, e.g., genetic hypersitosterolemia, are linked to increased coronary heart disease risk. For stanols, there is no evidence of such a risk. Development of lipid-dissolving stanol esters provided an opportunity to enrich various foods (spreads, yogurts, milk, etc.; trade mark Benecol, Raisio Company, Finland) with physiological stanol ester doses (1,5-2,0 g/d). Stanol consumption results in CH and low-density lipoprotein CH level decrease by 10-15%, in addition to low-lipid diet effects, and therefore could be used for prevention and treatment of atherogenic hypercholesterolemia.https://cardiovascular.elpub.ru/jour/article/view/1303plant stanols and sterolsabsorptioncholesterolnon-pharmaceutical preventionatherosclerosis
collection DOAJ
language Russian
format Article
sources DOAJ
author N. V. Perova
spellingShingle N. V. Perova
Non-pharmaceutical hypercholesterolemia management by plant stanol-enriched product consumption
Кардиоваскулярная терапия и профилактика
plant stanols and sterols
absorption
cholesterol
non-pharmaceutical prevention
atherosclerosis
author_facet N. V. Perova
author_sort N. V. Perova
title Non-pharmaceutical hypercholesterolemia management by plant stanol-enriched product consumption
title_short Non-pharmaceutical hypercholesterolemia management by plant stanol-enriched product consumption
title_full Non-pharmaceutical hypercholesterolemia management by plant stanol-enriched product consumption
title_fullStr Non-pharmaceutical hypercholesterolemia management by plant stanol-enriched product consumption
title_full_unstemmed Non-pharmaceutical hypercholesterolemia management by plant stanol-enriched product consumption
title_sort non-pharmaceutical hypercholesterolemia management by plant stanol-enriched product consumption
publisher «SILICEA-POLIGRAF» LLC
series Кардиоваскулярная терапия и профилактика
issn 1728-8800
2619-0125
publishDate 2006-10-01
description Phytosterols and phytostanols are plant analogs of cholesterol, inhibiting cholesterol (XCH) absorption by intestine epithelium and, therefore, decreasing CH blood levels. Sterols and especially stanols are absorbed in the intestine to a much lesser extent than CH, and their plasma concentrations are also less than those of CH. It is known that rare cases of hypercholesterolemia, e.g., genetic hypersitosterolemia, are linked to increased coronary heart disease risk. For stanols, there is no evidence of such a risk. Development of lipid-dissolving stanol esters provided an opportunity to enrich various foods (spreads, yogurts, milk, etc.; trade mark Benecol, Raisio Company, Finland) with physiological stanol ester doses (1,5-2,0 g/d). Stanol consumption results in CH and low-density lipoprotein CH level decrease by 10-15%, in addition to low-lipid diet effects, and therefore could be used for prevention and treatment of atherogenic hypercholesterolemia.
topic plant stanols and sterols
absorption
cholesterol
non-pharmaceutical prevention
atherosclerosis
url https://cardiovascular.elpub.ru/jour/article/view/1303
work_keys_str_mv AT nvperova nonpharmaceuticalhypercholesterolemiamanagementbyplantstanolenrichedproductconsumption
_version_ 1721271387045232640